Dynatronics Corporation Participates in Canaccord Genuity 2020 Medical Technologies & Diagnostics Forum

EAGAN, MN / ACCESSWIRE / November 19, 2020 / Dynatronics Corporation (NASDAQ:DYNT), a leading manufacturer of athletic training, physical therapy, and rehabilitation participated in the Canaccord 2020 Medical Technologies & Diagnostics Forum, that was held virtually today. John Krier, Chief Executive Officer and members of the Company’s leadership team provided an update to investors including a discussion of recently announced structural changes and the Company’s plans for pursuing future growth opportunities. All meetings were held in a 1-on-1 format.

“We were excited to participate in the Canaccord Forum to share our story and early results from our emerging, scalable business model,” explained Krier.

Investors are encouraged to access our updated investor presentation on the investor relations portion of our website at https://irdirect.net/dynt or alternatively request a copy of the presentation from Peter Seltzberg or Skyler Black.

About Dynatronics Corporation

Dynatronics is a leading medical device company committed to providing high-quality restorative products designed to accelerate achieving optimal health. The Company designs, manufactures, and sells a broad range of products for clinical use in physical therapy, rehabilitation, pain management, and athletic training. Through its distribution channels, Dynatronics markets and sells to orthopedists, physical therapists, chiropractors, athletic trainers, sports medicine practitioners, clinics, hospitals, and consumers. The Company’s products are marketed under a portfolio of high-quality, well-known industry brands including Bird & Cronin®, Solaris™, Hausmann™, Physician’s Choice®, and PROTEAM™, among others. More information is available at www.dynatronics.com.

CONTACT:

Dynatronics Corporation
Investor Relations
Skyler Black
(801) 676-7201
skyler.black@dynatronics.com

Darrow Associates, Inc.
Peter Seltzberg, Managing Director
Investor Relations
(516) 419-9915
pseltzberg@darrowir.com

For additional information, please visit: www.dynatronics.com
Connect with Dynatronics on LinkedIn

SOURCE: Dynatronics Corporation

View source version on accesswire.com:
https://www.accesswire.com/617655/Dynatronics-Corporation-Participates-in-Canaccord-Genuity-2020-Medical-Technologies-Diagnostics-Forum

Staff

Recent Posts

Hemostemix Announces ACP-01 Treatment-Purchase Available with Social Media Campaign Underway

Calgary, Alberta--(Newsfile Corp. - November 25, 2024) - Hemostemix Inc. (TSXV: HEM) (OTC Pink: HMTXF) (FSE:…

25 minutes ago

Maverick Medical AI, NewVue.ai, and RADPAIR Announce Strategic Integration to Reduce Burnout and Optimize Financial Performance

Real-Time Revenue Cycle Management and Clinical Workflow Optimization for Radiology Practices to Debut at RSNA…

2 hours ago

Cortechs.ai Partners with Mermaid Beach Radiology to Bring Precision AI Imaging Solutions to Their MRI and CT Services

SAN DIEGO, Nov. 25, 2024 /PRNewswire/ -- Cortechs.ai, a leading provider of AI-powered imaging solutions,…

2 hours ago

Chicago Tribune Names American Association of Nurse Anesthesiology a Winner of its Top Workplaces 2024 Award

ROSEMONT, Ill., Nov. 25, 2024 /PRNewswire/ -- The American Association of Nurse Anesthesiology (AANA) has…

2 hours ago

At AAEP 2024, Agfa showcases SmartRotate™ for Equine, powered by artificial intelligence

Specialized for veterinary care, SmartRotate™ for Equine automatically presents each image in the correct orientation,…

2 hours ago

Neurophet Secures FDA 510(k) Clearance for Multiple Sclerosis Analysis with ‘Neurophet AQUA’

New features include advanced analysis of multiple sclerosis (MS) and white matter hyperintensities alongside brain atrophy…

2 hours ago